Detection of chromothripsis-like patterns with a custom array platform for chronic lymphocytic leukemia.

scientific article published on 25 August 2015

Detection of chromothripsis-like patterns with a custom array platform for chronic lymphocytic leukemia. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1002/GCC.22277
P932PMC publication ID4832286
P698PubMed publication ID26305789
P5875ResearchGate publication ID281260201

P50authorElías CampoQ5830202
Marcos González DíazQ5996580
Itziar SalaverriaQ38319024
Julio DelgadoQ40386451
Sílvia BeàQ42886871
Dolors ColomerQ43096016
Alba NavarroQ48356856
Martin DyerQ53138021
Cristina LópezQ53260106
Guillem ClotQ55445114
David Martín GarciaQ57306252
Ana CarrióQ57572856
Ana M QueirósQ57630685
Marta AymerichQ60651570
Idoia Martin-GuerreroQ83569246
Sandrine JayneQ85885696
Armando López-GuillermoQ88697793
Neus VillamorQ89017470
Lluis ArmengolQ94513572
Tycho BaumannQ99586991
Magda PinyolQ117240573
P2093author name stringManel García-Aragonés
Reiner Siebert
Dolors Costa
P2860cites workAutomated array-based genomic profiling in chronic lymphocytic leukemia: development of a clinical tool and discovery of recurrent genomic alterationsQ24598248
International network of cancer genome projectsQ24611474
Array-based karyotyping for prognostic assessment in chronic lymphocytic leukemia: performance comparison of Affymetrix 10K2.0, 250K Nsp, and SNP6.0 arraysQ24614789
Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute-Working Group 1996 guidelinesQ24616084
Whole-genome scanning by array comparative genomic hybridization as a clinical tool for risk assessment in chronic lymphocytic leukemiaQ24642439
Customized oligonucleotide array-based comparative genomic hybridization as a clinical assay for genomic profiling of chronic lymphocytic leukemiaQ24657747
The biology and clinical significance of acquired genomic copy number aberrations and recurrent gene mutations in chronic lymphocytic leukemiaQ27024411
Monoallelic TP53 inactivation is associated with poor prognosis in chronic lymphocytic leukemia: results from a detailed genetic characterization with long-term follow-upQ27851444
Genomic aberrations and survival in chronic lymphocytic leukemiaQ28141442
Exome sequencing identifies recurrent mutations of the splicing factor SF3B1 gene in chronic lymphocytic leukemiaQ28255147
A genome-wide association study identifies multiple susceptibility loci for chronic lymphocytic leukemiaQ28943318
The patterns and dynamics of genomic instability in metastatic pancreatic cancerQ29618121
Chromosomal translocations and karyotype complexity in chronic lymphocytic leukemia: a systematic reappraisal of classic cytogenetic dataQ30685440
Assessment of fludarabine plus cyclophosphamide for patients with chronic lymphocytic leukaemia (the LRF CLL4 Trial): a randomised controlled trialQ33291990
Changes in the expression of telomere maintenance genes suggest global telomere dysfunction in B-chronic lymphocytic leukemiaQ33310158
Ibrutinib for previously untreated and relapsed or refractory chronic lymphocytic leukaemia with TP53 aberrations: a phase 2, single-arm trialQ33419580
Clinical impact of small TP53 mutated subclones in chronic lymphocytic leukemiaQ33595764
Addition of rituximab to fludarabine and cyclophosphamide in patients with chronic lymphocytic leukaemia: a randomised, open-label, phase 3 trialQ34141305
Non-nodal type of mantle cell lymphoma is a specific biological and clinical subgroup of the diseaseQ34231288
Genome sequencing of pediatric medulloblastoma links catastrophic DNA rearrangements with TP53 mutationsQ34248736
Progressive but previously untreated CLL patients with greater array CGH complexity exhibit a less durable response to chemoimmunotherapyQ34519192
Genome-wide analysis of DNA copy number changes and LOH in CLL using high-density SNP arrays.Q34575412
Evaluation of chronic lymphocytic leukemia by BAC-based microarray analysis.Q34608117
Array-based genomic screening at diagnosis and during follow-up in chronic lymphocytic leukemiaQ35143490
Acquired genomic copy number aberrations and survival in chronic lymphocytic leukemiaQ35220403
NOTCH1 mutations in CLL associated with trisomy 12.Q35669190
Quantification of subclonal distributions of recurrent genomic aberrations in paired pre-treatment and relapse samples from patients with B-cell chronic lymphocytic leukemiaQ36421804
CCND2 rearrangements are the most frequent genetic events in cyclin D1(-) mantle cell lymphomaQ36628297
Integrative genomic analysis implicates gain of PIK3CA at 3q26 and MYC at 8q24 in chronic lymphocytic leukemiaQ37037294
From pathogenesis to treatment of chronic lymphocytic leukaemiaQ37643423
Importance of genetics in chronic lymphocytic leukemiaQ37857481
ERIC recommendations on TP53 mutation analysis in chronic lymphocytic leukemiaQ37980658
Prognostic markers and their clinical applicability in chronic lymphocytic leukemia: where do we stand?Q38088354
Evaluation of chronic lymphocytic leukemia by oligonucleotide-based microarray analysis uncovers novel aberrations not detected by FISH or cytogenetic analysisQ39686496
Longitudinal genome-wide analysis of patients with chronic lymphocytic leukemia reveals complex evolution of clonal architecture at disease progression and at the time of relapse.Q41875368
Genomic complexity and IGHV mutational status are key predictors of outcome of chronic lymphocytic leukemia patients with TP53 disruptionQ42537560
Sporadic and reversible chromothripsis in chronic lymphocytic leukemia revealed by longitudinal genomic analysis.Q42789949
Improved detection rate of cytogenetic abnormalities in chronic lymphocytic leukemia and other mature B-cell neoplasms with use of CpG-oligonucleotide DSP30 and interleukin 2 stimulationQ43493099
Large genomic aberrations detected by SNP array are independent prognosticators of a shorter time to first treatment in chronic lymphocytic leukemia patients with normal FISH.Q44052389
The detection of TP53 mutations in chronic lymphocytic leukemia independently predicts rapid disease progression and is highly correlated with a complex aberrant karyotypeQ44461256
Deregulation of the telomerase reverse transcriptase (TERT) gene by chromosomal translocations in B-cell malignanciesQ44664483
Genomic imbalance defines three prognostic groups for risk stratification of patients with chronic lymphocytic leukemia.Q44882002
Detailed analysis of p53 pathway defects in fludarabine-refractory chronic lymphocytic leukemia (CLL): dissecting the contribution of 17p deletion, TP53 mutation, p53-p21 dysfunction, and miR34a in a prospective clinical trial.Q45915574
Clonal evolution in chronic lymphocytic leukemia: analysis of correlations with IGHV mutational status, NOTCH1 mutations and clinical significanceQ47916143
Comparison of array comparative genomic hybridization (aCGH) to FISH and cytogenetics in prognostic evaluation of chronic lymphocytic leukemia.Q51529353
Genome-wide DNA profiling better defines the prognosis of chronic lymphocytic leukaemia.Q51548976
Disruption of BIRC3 associates with fludarabine chemorefractoriness in TP53 wild-type chronic lymphocytic leukemia.Q52621343
Biallelic ATM inactivation significantly reduces survival in patients treated on the United Kingdom Leukemia Research Fund Chronic Lymphocytic Leukemia 4 trial.Q53137883
NOTCH1 mutations identify a genetic subgroup of chronic lymphocytic leukemia patients with high risk of transformation and poor outcome.Q53259951
Mutations in the ATM gene lead to impaired overall and treatment-free survival that is independent of IGVH mutation status in patients with B-CLL.Q53666581
High-resolution genomic profiling of chronic lymphocytic leukemia reveals new recurrent genomic alterationsQ57272648
Validation of a targeted DNA microarray for the clinical evaluation of recurrent abnormalities in chronic lymphocytic leukemiaQ57537886
Genome-wide DNA analysis identifies recurrent imbalances predicting outcome in chronic lymphocytic leukaemia with 17p deletionQ58001017
Gain of the short arm of chromosome 2 (2p) is a frequent recurring chromosome aberration in untreated chronic lymphocytic leukemia (CLL) at advanced stagesQ58041722
p53 gene deletion predicts for poor survival and non-response to therapy with purine analogs in chronic B-cell leukemiasQ72626720
11q deletions identify a new subset of B-cell chronic lymphocytic leukemia characterized by extensive nodal involvement and inferior prognosisQ73260738
A novel fusion of the MALT1 gene and the microtubule-associated protein 4 (MAP4) gene occurs in diffuse large B-cell lymphomaQ79805104
Atypical 11q deletions identified by array CGH may be missed by FISH panels for prognostic markers in chronic lymphocytic leukemiaQ83214944
Large but not small copy-number alterations correlate to high-risk genomic aberrations and survival in chronic lymphocytic leukemia: a high-resolution genomic screening of newly diagnosed patientsQ84537035
P433issue11
P921main subjectlymphocyteQ715347
P304page(s)668-680
P577publication date2015-08-25
P1433published inGenes, Chromosomes and CancerQ5532697
P1476titleDetection of chromothripsis-like patterns with a custom array platform for chronic lymphocytic leukemia
P478volume54